Weixiong Xia

6PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 06, 2026
Systemic Inflammation Mediates the Association Between Plasma Epstein-Barr Virus DNA and Mortality in Metastatic Nasopharyngeal Carcinoma.

|Feb 08, 2026
Multimodal glyco-lipid-EBVDNA signature prognostic model for individualized risk stratification of locally advanced nasopharyngeal carcinoma.

Jiayu Zhou, Yuchen Hua, Chuanrun Zhang

|May 19, 2025
Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial.

Xun Cao, Zhuo-Ying Luo, Hao-Yang Huang

|Dec 21, 2019
Deep learning pathological microscopic features in endemic nasopharyngeal cancer: Prognostic value and protentional role for individual induction chemotherapy.

Kuiyuan Liu, Weixiong Xia, Mengyun Qiang

|Dec 14, 2019
Prognostic value of early radiological response to first-line platinum-containing chemotherapy in patients with metastatic nasopharyngeal carcinoma.

Guo-Ying Liu, Wang-Zhong Li, Kang-Qiang Peng

|Aug 16, 2018
Platinum-based concurrent chemotherapy remains the optimal regimen for nasopharyngeal carcinoma: a large institutional-based cohort study from an endemic area.

Yahui Yu, Hu Liang, Xing Lv

Pageof 1

Frequent Collaborators

2 joint publications

Kuiyuan Liu

1 joint publications

Guo-Ying Liu

1 joint publications

Wang-Zhong Li

1 joint publications

Yan-Qun Xiang